Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Ankica Vujović"'
Autor:
Miloš Korać, Maja Rupnik, Nataša Nikolić, Milica Jovanović, Tanja Tošić, Jovan Malinić, Nikola Mitrović, Marko Marković, Ankica Vujović, Sanja Peruničić, Ksenija Bojović, Vladimir Djordjević, Aleksandra Barać, Ivana Milošević
Publikováno v:
Gut Pathogens, Vol 12, Iss 1, Pp 1-6 (2020)
Abstract Background The global epidemic of nosocomial diarrhea caused by Clostridioides (Clostridium) difficile started in 2000, with high mortality rates and emergence of a new hypervirulent strain NAP1/BI/027. The aim of this study was to assess th
Externí odkaz:
https://doaj.org/article/893078a9d8c54821bcd8a72c405ca3c1
Autor:
Ivana Milošević, Aleksandra Barać, Jaroslava Jovanović, Ankica Vujović, Goran Stevanović, Nevena Todorović, Branko Milošević
Publikováno v:
Transactions of The Royal Society of Tropical Medicine and Hygiene.
Background We investigated the therapeutic response of tocilizumab (TCZ) therapy in patients with coronavirus disease 2019 (COVID-19) pneumonia. Methods This observational retrospective study included 205 patients with confirmed COVID-19 pneumonia wi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5637541141c9467955a9237517e8b2a1
https://doi.org/10.1093/trstmh/trad026
https://doi.org/10.1093/trstmh/trad026
Autor:
Aleksandra Barac, Ankica Vujovic, Ana Drazic, Goran Stevanovic, Bianca Paglietti, Katarina Lukic, Maja Stojanovic, Mihailo Stjepanovic
Publikováno v:
Journal of Fungi, Vol 9, Iss 11, p 1084 (2023)
Chronic pulmonary aspergillosis (CPA) is a chronic progressive lung disease associated with a poor prognosis and a 5-year mortality rate of approximately 40–50%. The disease is characterized by slowly progressive destruction of the lung parenchyma,
Externí odkaz:
https://doaj.org/article/d47e548816074e08a9f95f7904a34471
Autor:
Aleksa Despotovic, Branko Milosevic, Andja Cirkovic, Ankica Vujovic, Ksenija Cucanic, Teodora Cucanic, Goran Stevanovic
Publikováno v:
Antibiotics, Vol 10, Iss 10, p 1146 (2021)
Hospital-acquired infections (HAIs) are a global public health concern. As the COVID-19 pandemic continues, its contribution to mortality and antimicrobial resistance (AMR) grows, particularly in intensive care units (ICUs). A two-year retrospective
Externí odkaz:
https://doaj.org/article/50824b39a44d41d1b79567d56c92b60a